Recruiting Schizophrenia Studies in Hollywood
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg o...
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults....
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
This is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose regiments of KYN-5356 ...
Study of ALTO-101 in Patients With Schizophrenia
This is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers an...
About Schizophrenia Clinical Trials in Hollywood
Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.
There are currently 4 schizophrenia clinical trials recruiting participants in Hollywood, FLORIDA. These studies are seeking a combined 1,206 participants. Research is being sponsored by Reviva Pharmaceuticals, Neurocrine Biosciences, Kynexis B.V. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Schizophrenia Clinical Trials in Hollywood — FAQ
Are there schizophrenia clinical trials in Hollywood?
Yes, there are 4 schizophrenia clinical trials currently recruiting in Hollywood, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hollywood?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hollywood research site will contact you about next steps.
Are clinical trials in Hollywood free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hollywood studies also compensate for your time and travel.
What schizophrenia treatments are being tested?
The 4 active trials in Hollywood are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.
Data updated March 2, 2026 from ClinicalTrials.gov